Cargando…

Revised Modelling of the Addition of Synchronous Chemotherapy to Radiotherapy in Squamous Cell Carcinoma of the Head and Neck—A Low α/β?

Background: The effect of synchronous chemotherapy in squamous cell carcinoma of the head and neck (SCCHN) has been modelled as additional Biologically Effective Dose (BED) or as a prolonged tumour cell turnover time during accelerated repopulation. Such models may not accurately predict the local c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Best, James, Fong, Charles, Benghiat, Helen, Mehanna, Hisham, Glaholm, John, Hartley, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023462/ https://www.ncbi.nlm.nih.gov/pubmed/29899241 http://dx.doi.org/10.3390/medicines5020054

Ejemplares similares

Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial
por: Vreugdenhil, M., et al.
Publicado: (2021)

Head and neck surgery recommendations during the COVID-19 pandemic – Author's reply
por: Mehanna, Hisham
Publicado: (2020)

Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck
por: Ali, Elsayed M, et al.
Publicado: (2011)

Head and Neck Squamous Cell Carcinoma in Elderly Patients: Role of Radiotherapy and Chemotherapy
por: Fasano, Morena, et al.
Publicado: (2022)

Characterizing the epithelial–mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma
por: Payne, Karl, et al.
Publicado: (2022)

Glutathione S-transferase Polymorphisms in Head and Neck Squamous Cell Carcinoma Treated with Chemotherapy and/or Radiotherapy
por: Maniglia, Mauricio Pereira, et al.
Publicado: (2020)

Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma
por: Hollows, Robert, et al.
Publicado: (2018)

Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma
por: Bryant, Jennifer, et al.
Publicado: (2019)

Accelerated Radiotherapy with Concurrent Chemotherapy in Locally Advanced Head and Neck Cancers: Evaluation of Response and Compliance
por: Mashhour, Karim, et al.
Publicado: (2020)

Inhibitors of Ceramide- and Sphingosine-Metabolizing Enzymes as Sensitizers in Radiotherapy and Chemotherapy for Head and Neck Squamous Cell Carcinoma
por: Yura, Yoshiaki, et al.
Publicado: (2020)

Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping
por: Payne, Karl, et al.
Publicado: (2023)

Comprehensive Genomic and Transcriptomic Analysis of Three Synchronous Primary Tumours and a Recurrence from a Head and Neck Cancer Patient
por: Bresadola, Luisa, et al.
Publicado: (2021)

Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma
por: Van Gestel, Dirk, et al.
Publicado: (2020)

Efficacy of intensity-modulated radiotherapy combined with chemotherapy or surgery in locally advanced squamous cell carcinoma of the head-and-neck
por: Yang, Hua, et al.
Publicado: (2013)

Circulating Tumour Cell Expression of Immune Markers as Prognostic and Therapeutic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Payne, Karl, et al.
Publicado: (2020)

Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial
por: Tobias, Jeffrey S, et al.
Publicado: (2009)

Adapting Head and Neck Cancer Management in the Time of COVID-19
por: Mehanna, Hisham, et al.
Publicado: (2020)

A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck
por: Budach, W, et al.
Publicado: (2006)

Oral shedding of human herpesviruses in patients undergoing radiotherapy/chemotherapy for head and neck squamous cell carcinoma is not affected by xerostomia
por: Palmieri, Michelle, et al.
Publicado: (2018)

Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol
por: Kong, Anthony, et al.
Publicado: (2020)

Plasma prostaglandins in mucositis due to radiotherapy and chemotherapy for head and neck cancer.
por: Tanner, N. S., et al.
Publicado: (1981)

Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy
por: Chen, Yen-Hao, et al.
Publicado: (2020)

Value of oesophagoscopy and bronchoscopy in diagnosis of synchronous malignancies in patients with head and neck squamous cell carcinomas
por: Ho, Shi Yeung, et al.
Publicado: (2020)

Endoscopy under general anesthesia for detecting synchronous lesions of head and neck squamous cell carcinoma
por: Noh, Jin Hee, et al.
Publicado: (2023)

Barriers to recruitment for surgical trials in head and neck oncology: a survey of trial investigators
por: Kaur, Geetinder, et al.
Publicado: (2013)

Reprogramming of Energy Metabolism in Response to Radiotherapy in Head and Neck Squamous Cell Carcinoma
por: Cruz-Gregorio, Alfredo, et al.
Publicado: (2019)

The impact of national holidays on postoperative radiotherapy of squamous cell carcinoma of the head and neck
por: Kim, Michael S., et al.
Publicado: (2023)

Palmar-plantar erythrodysesthesia secondary to docetaxel chemotherapy: a case report
por: Benghiat, Helen, et al.
Publicado: (2011)

Circulating Tumour Cell Biomarkers in Head and Neck Cancer: Current Progress and Future Prospects
por: Payne, Karl, et al.
Publicado: (2019)

Concomitant Radiotherapy and Chemotherapy for High-Risk Nonmelanoma Skin Carcinomas of the Head and Neck
por: Apisarnthanarax, Smith, et al.
Publicado: (2011)

Audiometric Patterns in Ototoxicity After Radiotherapy and Chemotherapy in Patients of Head and Neck Cancers
por: Malgonde, Monika Shamrao, et al.
Publicado: (2015)

Synchronous squamous cell carcinoma and diffuse large B-cell lymphoma of the head and neck: the odd couple
por: Raldow, Ann C, et al.
Publicado: (2016)

Adjuvant Postoperative Radiotherapy with or without Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: The Importance of Patient Selection for the Postoperative Chemoradiotherapy
por: Lee, Jong Hoon, et al.
Publicado: (2013)

Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers
por: Kanno, Yuzuka, et al.
Publicado: (2021)

Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Question of Belief
por: Karabajakian, Andy, et al.
Publicado: (2018)

p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy
por: Ganly, I, et al.
Publicado: (2000)

Can Intensity-Modulated-Radiotherapy Reduce Toxicity in Head and Neck Squamous Cell Carcinoma?
por: van der Veen, Julie, et al.
Publicado: (2017)

Overcoming the Impact of Hypoxia in Driving Radiotherapy Resistance in Head and Neck Squamous Cell Carcinoma
por: Hill, Rhianna M., et al.
Publicado: (2022)

Individualized elective irradiation of the clinically node‐negative neck in definitive radiotherapy for head and neck squamous cell carcinoma
por: Kou, Jia, et al.
Publicado: (2021)

Synchronous Metastatic Nasopharyngeal Carcinoma: Characteristics and Survival of Patients Adding Definitive Nasopharyngeal-Neck Radiotherapy to Systematic Chemotherapy
por: Liao, Wenjun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ijmtbl2987jr0l8iet6e1oe7am